Literature DB >> 12937886

Methodological approaches for the study of GABA(A) receptor pharmacology and functional responses.

Alison J Smith1, Peter B Simpson.   

Abstract

Inhibitory GABA(A) receptor ion channels are the target for a wide range of clinically-used therapeutic agents. The complex structural diversity of these ligand-gated channels, revealed by molecular cloning studies, together with increasing requirements for higher-throughput functional assays in drug discovery, has led to the development of a wide range of techniques to examine GABA(A) receptor pharmacology and function. In the current article we review some of the methodologies which have contributed to the expansion of knowledge in this field. The techniques include: molecular approaches, immunoprecipitation, and immunopurification to study receptor assembly, structure, and functional expression; in situ hybridization, immunocytochemistry, and autoradiography to examine receptor distribution in native tissues; radioligand binding, site-directed mutagenesis, and electrophysiology to examine pharmacology and allosteric modulation; and patch clamp, ion flux, microphysiometry, and a variety of novel fluorescence-based technologies to examine ion-channel function. The use of gene targetting approaches in transgenic mice has also provided important insights into the role of specific GABA(A) receptor subtypes in vivo. The continuing evolution of novel technologies and assay approaches with appropriate sensitivity and resolution to measure subtle modulation of GABA(A) ion channels will facilitate ongoing investigation of the physiological functions of these important inhibitory receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937886     DOI: 10.1007/s00216-003-2172-y

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  7 in total

1.  Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons.

Authors:  Mayur Patil; Amol Patwardhan; Margaux M Salas; Kenneth M Hargreaves; Armen N Akopian
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

2.  Salicylidene salicylhydrazide, a selective inhibitor of beta 1-containing GABAA receptors.

Authors:  S A Thompson; L Wheat; N A Brown; P B Wingrove; G V Pillai; P J Whiting; C Adkins; C H Woodward; A J Smith; P B Simpson; I Collins; K A Wafford
Journal:  Br J Pharmacol       Date:  2004-04-20       Impact factor: 8.739

3.  Antioxidants L-carnitine and D-methionine modulate neuronal activity through GABAergic inhibition.

Authors:  Calvin Wu; Kamakshi V Gopal; Ernest J Moore; Guenter W Gross
Journal:  J Neural Transm (Vienna)       Date:  2014-02-15       Impact factor: 3.575

Review 4.  Clerodane Diterpenes from Casearia corymbosa as Allosteric GABAA Receptor Modulators.

Authors:  Nova Syafni; Maria Teresa Faleschini; Aleksandra Garifulina; Ombeline Danton; Mahabir P Gupta; Steffen Hering; Matthias Hamburger
Journal:  J Nat Prod       Date:  2022-04-27       Impact factor: 4.803

5.  Yellow fluorescent protein-based assay to measure GABA(A) channel activation and allosteric modulation in CHO-K1 cells.

Authors:  Teres Johansson; Tyrrell Norris; Helena Peilot-Sjögren
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

6.  Sedative-Hypnotic and Receptor Binding Studies of Fermented Marine Organisms.

Authors:  Hye-Young Joung; Young Mi Kang; Bae-Jin Lee; Sun Yong Chung; Kyung-Soo Kim; Insop Shim
Journal:  Biomol Ther (Seoul)       Date:  2015-09-01       Impact factor: 4.634

7.  Sedative-Hypnotic Activity of the Water Extracts of Coptidis Rhizoma in Rodents.

Authors:  Hye-Young Joung; Minsook Ye; Miyoung Lee; Yunki Hong; Minji Kim; Kyung Soo Kim; Insop Shim
Journal:  Clocks Sleep       Date:  2022-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.